Management of adverse events of targeted therapies in normal and special patients with metastatic renal cell carcinoma.

Cancer metastasis reviews

Volumn 31 Suppl 1, Issue , 2012, Pages

  Méndez Vidal, María José ^a   Martínez Ortega, Esther ^b   Montesa Pino, Alvaro ^b   Pérez Valderrama, Begoña ^b   Viciana, Ruth ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METASTASIS; PATHOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEOPLASM METASTASIS;

MLCS; MLOWN;

EID: 85027956253     PISSN: None     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9355-y     Document Type: Review

References (0)